(Q42987319)

12 November 2017

title

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa (English)

1 reference

12 November 2017

1 reference

1 reference

S Zeuzem

1

1 reference

12 November 2017

J H Lee

2

1 reference

12 November 2017

A Franke

3

1 reference

12 November 2017

B Rüster

4

1 reference

12 November 2017

O Prümmer

5

1 reference

12 November 2017

G Herrmann

6

1 reference

12 November 2017

W K Roth

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

12 November 2017

1 reference

12 November 2017

volume

27

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

1149-1156

1 reference

Hepatitis C virus six years on.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Genetic organization and diversity of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Avoiding false positives with PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Confidence Limits on Phylogenies: an Approach using the Bootstrap

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Reliability of polymerase chain reaction for detection of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

HCV viraemia is more important than genotype as a predictor of response to interferon in sicily (Southern Italy)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

7 January 2021

Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial. The Delta-P Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

7 January 2021

Sensitive antiproliferative neutralization assay for the detection of neutralizing IFN-alpha and IFN-beta antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

7 January 2021

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

7 January 2021

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

7 January 2021

An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

7 January 2021

Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

7 January 2021

Clinical significance of anti-IFN-alpha antibody titres during interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

7 January 2021

Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

7 January 2021

Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270433

7 January 2021

Identifiers

DOI

10.1002/HEP.510270433

1 reference

12 November 2017

1 reference